Skip to main content
. 2024 Jan 24;15:1288362. doi: 10.3389/fphar.2024.1288362

FIGURE 5.

FIGURE 5

Adverse events involving nervous system disorders. (A) Distribution of the total number and percentage of patients with concomitant nervous system disorders in reports of HER2 monotherapy. (B) Bar graph statistics of the proportion and number of cases of living and dead patients presenting with nervous system disorders, and those not explicitly labeled in the outcome list have been excluded. (C) Mulberry map of clinical characteristics of patients with nervous system disorders. (D) Comparison of positive signal with nervous system disorders obtained by different HER2 inhibitors based on the Proportional Reporting Ratio (PRR) method. Red dots indicate PRR values in the 2.0–6.0 range. Blue dots indicate PRR values above 5.0.